A newly released report from the American Cancer Society (ACS), published in CA: A Cancer Journal for Clinicians, offers encouraging news about overall cancer mortality rates in the United States while also highlighting persistent disparities among different communities. The report notes that, thanks to advances in screening and treatment, the nation has seen a continued decline in deaths from several major cancers. This trend reflects progress in early detection, new therapies, and ongoing public health initiatives aimed at reducing risk factors such as smoking. ...
Disparities in Prostate Cancer
Advertisement
Less than half of VA hospitals are sites for prostate cancer clinical trials.
Prostate-specific antigen (PSA) velocity and PSA values taken together may improve the specificity of monitoring.
Patients and survivors who engaged in physical activity experienced a protective effect on mental health.
Contaminants, such as heavy metals, pesticides, and microbial pathogens, may influence cancer severity.
Patients and caregivers most valued the role of genetics in understanding risk stratification.
The rate of prostate cancer mortality is higher in parts of the United States where structural racism is also higher.
The slower recovery PSA screening rate in Black men highlights the persistent racial disparities in health care access.
In this analysis, the model performed best for predicting survival Asian patients and worst for Non-Hispanic Black patients.
Advertisement
Expert Interviews
Dr. Cedric Pulliam's personal journey to an IBD diagnosis and patient advocacy work to raise awareness.
Dr. Von Nguyen, Chief Clinical Officer at Evolent, discusses the use of AI and technology in medicine and population health.
Drs. Julia Schulz and Michael Dovidio discuss lab values to determine GLP-1 drug coverage and improve prescription access.
Dr. Kamal Golla of Evolent discusses specialist engagement with primary care physicians for high-quality patient care.
Patient advocate and influencer Alisha Bridges talks about living with Plaque & Scalp Psoriasis as a person of color.
Dr. Luke Twelves, VP of Medical for Lindus Health discusses the lack of diversity in type 2 diabetes clinical trials.
Urban Health Today reports on clinical news and policy updates that directly impact urban health care providers and their patients.
Get research and expert insights straight to your inbox.